Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes (Q29619437)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

eradication of infectious diseases

30 April 2017

main subject

1 reference

1 reference

1 reference

8

Raposo G

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

30 April 2017

author name string

Zitvogel L

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

30 April 2017

Regnault A

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

30 April 2017

Lozier A

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

30 April 2017

Wolfers J

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

30 April 2017

Flament C

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

30 April 2017

Tenza D

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

30 April 2017

Ricciardi-Castagnoli P

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

30 April 2017

Amigorena S

9

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

30 April 2017

language of work or name

1 reference

30 April 2017

publication date

May 1998

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

30 April 2017

volume

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

30 April 2017

issue

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

30 April 2017

page(s)

594-600

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9585234

Human tumor antigens recognized by T lymphocytes

30 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Cytokine gene therapy of cancer using interleukin-12: murine and clinical trials.

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

The new vaccines: building viruses that elicit antitumor immunity.

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Both dendritic cells and memory T lymphocytes emigrate from organ cultures of human skin and form distinctive dendritic-T-cell conjugates

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Dendritic cells hold promise for immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Developmental regulation of MHC class II transport in mouse dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

B lymphocytes secrete antigen-presenting vesicles

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors.

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Cell-free tumor antigen peptide-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Transferrin receptors during rabbit reticulocyte maturation

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0598-594

7 January 2021

Identifiers

DOI

10.1038/NM0598-594

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

835072

Dimensions Publication ID

1001835763

0 references

OpenCitations bibliographic resource ID

835072

1 reference